{"transactions":[{"id":836031,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":59606,"kind":"person","name":"Schabacker Matthew","position":1,"cik":"0002066553","reported_name":"Schabacker Matthew","relationship":{"officer":true,"officer_title":"VP GM Advanced Surgical"}}],"security":"RSUs (Restricted Stock Units)","published_at":"2026-03-18T18:04:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":17471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the \"Company\") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first  33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,827 shares for a total of 17,471 RSUs granted."}],"balance_after":17471,"derivative":{"exercise_price":0,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":17471},"source":{"system":"sec-edgar","filing":"0000816956-26-000037","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816956/000081695626000037/form4a.xml","form_type":"4/A","original_submission_date":"2026-03-04"}},{"id":863621,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":59606,"kind":"person","name":"Schabacker Matthew","position":1,"cik":"0002066553","reported_name":"Schabacker Matthew","relationship":{"officer":true,"officer_title":"VP GM Advanced Surgical"}}],"security":"Options To Purchase Common Stock","published_at":"2026-03-04T21:04:11.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":11646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date."}],"balance_after":11646,"derivative":{"exercise_price":45.79,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":11646},"source":{"system":"sec-edgar","filing":"0000816956-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816956/000081695626000027/form4.xml","form_type":"4"}},{"id":863620,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":59606,"kind":"person","name":"Schabacker Matthew","position":1,"cik":"0002066553","reported_name":"Schabacker Matthew","relationship":{"officer":true,"officer_title":"VP GM Advanced Surgical"}}],"security":"RSUs (Restricted Stock Units)","published_at":"2026-03-04T21:04:11.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":9827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the \"Company\") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first  33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year."}],"balance_after":9827,"derivative":{"exercise_price":0,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":9827},"source":{"system":"sec-edgar","filing":"0000816956-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816956/000081695626000027/form4.xml","form_type":"4"}},{"id":1162935,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":59606,"kind":"person","name":"Schabacker Matthew","position":1,"cik":"0002066553","reported_name":"Schabacker Matthew","relationship":{"officer":true,"officer_title":"VP GM Advanced Surgical"}}],"security":"Options To Purchase Common Stock","published_at":"2025-05-01T20:28:02.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":31675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period"}],"balance_after":31675,"derivative":{"exercise_price":50.84,"expiration_date":"2035-04-28","underlying":"Common Stock","underlying_shares":31675},"source":{"system":"sec-edgar","filing":"0001127602-25-012933","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816956/000112760225012933/form4.xml","form_type":"4"}}]}